[go: up one dir, main page]

AU2002216040A1 - Method of prognosis and diagnosis of congestive heart failure - Google Patents

Method of prognosis and diagnosis of congestive heart failure

Info

Publication number
AU2002216040A1
AU2002216040A1 AU2002216040A AU1604002A AU2002216040A1 AU 2002216040 A1 AU2002216040 A1 AU 2002216040A1 AU 2002216040 A AU2002216040 A AU 2002216040A AU 1604002 A AU1604002 A AU 1604002A AU 2002216040 A1 AU2002216040 A1 AU 2002216040A1
Authority
AU
Australia
Prior art keywords
prognosis
diagnosis
heart failure
congestive heart
congestive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216040A
Inventor
Franz Paul Armbruster
Thomas Dschietzig
Hans-Jurgen Gron
Karl Stangl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immundiagnostik AG
Original Assignee
Immundiagnostik AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immundiagnostik AG filed Critical Immundiagnostik AG
Publication of AU2002216040A1 publication Critical patent/AU2002216040A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/64—Relaxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002216040A 2000-11-16 2001-11-15 Method of prognosis and diagnosis of congestive heart failure Abandoned AU2002216040A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00125053.9 2000-11-16
EP00125053 2000-11-16
PCT/EP2001/013236 WO2002040500A2 (en) 2000-11-16 2001-11-15 Method of prognosis and diagnosis of congestive heart failure

Publications (1)

Publication Number Publication Date
AU2002216040A1 true AU2002216040A1 (en) 2002-05-27

Family

ID=8170402

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216040A Abandoned AU2002216040A1 (en) 2000-11-16 2001-11-15 Method of prognosis and diagnosis of congestive heart failure

Country Status (3)

Country Link
AU (1) AU2002216040A1 (en)
DE (1) DE10155843A1 (en)
WO (1) WO2002040500A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7878978B2 (en) 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
WO2009140657A2 (en) * 2008-05-16 2009-11-19 Corthera, Inc. Method of treating chronic heart failure
AR071810A1 (en) * 2008-05-16 2010-07-14 Corthera Inc METHOD OF TREATMENT OF DISNEA ASSOCIATED WITH ACUTE CARDIAC INSUFFICIENCY. RELAXIN H2. USE.
CN110607360A (en) * 2019-09-19 2019-12-24 华中科技大学同济医学院附属同济医院 A primer set, kit and method for evaluating the prognosis of chronic heart failure
CN119947743A (en) 2022-08-31 2025-05-06 雷拉科斯拉制药有限责任公司 Immunosuppressive drugs and treatments
WO2025056188A1 (en) 2023-09-15 2025-03-20 Relaxera Pharmazeutische Gmbh & Co. Kg Relaxin medication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
US6251863B1 (en) * 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin

Also Published As

Publication number Publication date
DE10155843A1 (en) 2003-01-30
WO2002040500A3 (en) 2002-09-12
WO2002040500A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU2001243273A1 (en) System and method for diagnosing pathologic heart conditions
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
AU2001252973A1 (en) Biosensor and related method
AU4856500A (en) Acoustic transducer and method of making the same
AU8007000A (en) Integrated forms and method of making such forms
AU4422800A (en) Method of analysis of medical signals
AU4238500A (en) Method of obtaining an electronically-stored financial document
AU2002364277A1 (en) Method for the assessment and prognosis of sarcoidosis
AU2002230606A1 (en) Glazing unit and method of making the same
AU4819899A (en) Coupling half and method of making same
AU2001276957A1 (en) Method of diagnosing pulmonary hypertension
AU3938299A (en) Method of altering heartbeat
AU5116100A (en) Connector and method of use of the connector
AU2834500A (en) Method of testing hearing by means of personal computers
AU2002216040A1 (en) Method of prognosis and diagnosis of congestive heart failure
AU2002366813A1 (en) Cardiac pacing method and system
AU2002237253A1 (en) Biosensor and method of producing the same
AU2728901A (en) Method of making hydrofluorocarbons
AU6923800A (en) A method of performing securitized transactions
AU2003276398A1 (en) Shearwall structure and method of making the same
AU2001212603A1 (en) Method for management of blood glucose levels
AU6533700A (en) Methods of gene expression monitoring
AU2002319080A1 (en) Method for the diagnosis and therapy of renal cell carcinoma
AU6000600A (en) Diagnostic method
AU2194801A (en) Diagnostic method